E14 SPV Culture Biosciences B LLC
E14 · adviser of record: E14 Management, LLC · 2021 vintage
E14 SPV Culture Biosciences B LLC is a 2021 venture fund managed by E14, with $4.7mm raised (Form D, amount sold). It reported $4.6mm in gross assets at year-end 2023, 0.99x its size, against a peak of $4.7mm in 2021.
- Latest value held
- $4.6mm year-end 2023
- Peak
- $4.7mm year-end 2021
- Fund size
- $4.7mm Form D, amount sold
- Held vs. size
- 0.99x peak 1.00x
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2023 | $4.6mm | 0.99x | -0% |
| 2022 | $4.7mm | 0.99x | -0% |
| 2021 | $4.7mm | 1.00x | – |
Other funds from E14
- E14 Fund 3 Limited Partnership 2022
- E14 SPV Opt Industries A, LLC 2022
- E14 SPV Volta Labs A, LLC 2022
- E14 SPV Overjet B, LLC 2021
- E14 SPV Overjet A, LLC 2021
- E14 2020 Fund, LP 2020
- E14 2017 Fund, LP 2017
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-1108924952. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.